Olba DVx Healthcare (TSE:2689) Change In Receivables: 円 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2689 Olba DVx Healthcare Inc TSE:2689
62 GF Score
Price 円1,925.00
GF Value 円2,164.82
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Olba DVx Healthcare Change In Receivables?

Olba DVx Healthcare TSE:2689 62 Change In Receivables is 円 Mil as of Jun. 2026. GuruFocus rates TSE:2689 with a GF Score™ of 62/100 and a GF Value™ of 円2,164.82 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Olba DVx Healthcare's change in receivables for the quarter that ended in Jun. 2026 was 円 Mil. It means Olba DVx Healthcare's Accounts Receivable stayed the same from Mar. 2026 to Jun. 2026 .

Olba DVx Healthcare's change in receivables for the fiscal year that ended in Jun. 2026 was 円-531 Mil. It means Olba DVx Healthcare's Accounts Receivable increased by 円531 Mil from Jun. 2025 to Jun. 2026 .

Olba DVx Healthcare's Accounts Receivable for the quarter that ended in Jun. 2026 was 円26,885 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Olba DVx Healthcare's Days Sales Outstanding for the three months ended in Jun. 2026 was 79.60.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Olba DVx Healthcare's liquidation value for the three months ended in Jun. 2026 was 円-7,366 Mil.

Olba DVx Healthcare  (TSE:2689) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Olba DVx Healthcare's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=26884.526/30818.004*91
=79.60

2. In Ben Graham's calculation of liquidation value, Olba DVx Healthcare's accounts receivable are only considered to be worth 75% of book value:

Olba DVx Healthcare's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2640.512-33592.515+0.75 * 26884.526+0.5 * 6844.541
=-7,366

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olba DVx Healthcare Change In Receivables Related Terms

Olba DVx Healthcare Change In Receivables Historical Data

* Premium members only.

The historical data trend for Olba DVx Healthcare's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olba DVx Healthcare Change In Receivables Chart

Olba DVx Healthcare Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,595.43 -937.75 -1,593.36 -256.66 -531.10

Olba DVx Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
TSE:2689
62GF Score
Olba DVx Healthcare Inc TSE:2689
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olba DVx Healthcare Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of 円 Mil mean?
Olba DVx Healthcare (TSE:2689) has a Change In Receivables of 円 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Olba DVx Healthcare and its competitors.
Is Olba DVx Healthcare's Change In Receivables too high?
Olba DVx Healthcare's current Change In Receivables is 円 Mil. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's Change In Receivables compare to MCK and COR?
Olba DVx Healthcare's Change In Receivables of 円 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Distribution company?
A good Change In Receivables depends on the Medical Distribution industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Olba DVx Healthcare and its competitors. Olba DVx Healthcare's current Change In Receivables is 円 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,164.82, compared to a current price of 円1,925.00 — trading 11.1% below its estimated fair value. The current Change In Receivables is 円 Mil. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current Change In Receivables is 円 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?

Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued. The current stock price of 円1,925.00 is trading 11.1% below its estimated GF Value™ of 円2,164.82. GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.

Key valuation signals for TSE:2689:

  • Change In Receivables: 円 Mil
  • GF Value™: 円2,164.82 vs. price of 円1,925.00 (11.1% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Olba DVx Healthcare Business Description

Address 1-1-3 Shimoishii, Kita-ku, 8th Floor, Nippon Life Insurance Okayama Dai-ni Building, Okayama Prefecture, Okayama, JPN, 700-0907
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score

Get the complete analysis for TSE:2689

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,925.00
Price
円2,164.82
GF Value